July 18th 2025
The new presentation of Shingrix will allow for easier administration.
Immunizations Update 2024: Advancing the Role of the Pharmacy Technician in Vaccine Administration
1.0 Credit / Immunization
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
Exploring Immunizations Updates and Strategies for Addressing Vaccine Hesitancy
1.0 Credit / Immunization
View More
The Essential Role of Pharmacists in Improving Influenza Vaccination Coverage: Strategies to Increase Vaccine ...
1.0 Credit / Immunization, Infectious Diseases
View More
The Role of Pharmacists in Pneumococcal Prevention: Strategies to Improve Vaccine Uptake
1.0 Credit / Immunization, Infectious Diseases, Pulmonology
View More
Insights in Influenza Immunization: The Long-Term Care Pharmacist’s Role in Improving Health Outcomes in At-Ri...
1.0 Credit / Immunization, Infectious Diseases
View More
Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Pharma...
0.5 Credit / Immunization
View More
Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion (Pharmacy Technicia...
0.75 Credit / Immunization
View More
Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion
0.75 Credit / Immunization
View More
Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Part 1...
0.5 Credit / Immunization
View More
Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Part 2)
0.5 Credit / Immunization
View More
Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Part...
0.5 Credit / Immunization
View More
Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Pharmacy...
0.5 Credit / Immunization
View More
Beyond the Spots: Management of Measles
1.0 Credit / Infectious Disease, Immunization
View More
Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage
1.5 Credits / Immunization, Infectious Disease, Pulmonology
View More
PBM Challenges and the Evolving Role of Oncology Pharmacists in Community Practices
0.75 Credit / Oncology, Law
View More
Discipline Decoded: Navigating Pharmacy Law and Disciplinary Cases
1.0 Credit / General Pharmacy, Law
View More
Understanding and Personalizing Chronic Obstructive Pulmonary Disease Diagnosis and Treatment
1.0 Credit / Infectious Disease, Immunization
View More
Discipline Decoded: Navigating Pharmacy Law and Disciplinary Cases (Pharmacy Technician Credit)
1.0 Credit / General Pharmacy, Law
View More
Respiratory Syncytial Virus Disease Prevention in Adults: The Pharmacist’s Role in Improving Vaccine Uptake
1.0 Credit / Immunization
View More
Despite Pandemic Fatigue, Health Care Providers Can Help Ease COVID-19 Vaccine Hesitancy
August 27th 2024Chijioke Bennett, executive director of clinical development at Novavax, discusses how health care providers can increase awareness around COVID-19 vaccination and how to help patients overcome vaccine hesitancy.
HHS Awards Moderna $176 Million to Develop Pandemic-Ready Influenza Vaccine
July 4th 2024“Adding this technology to our pandemic flu toolkit enhances our ability to be nimble and quick against the circulating strains and their potential variants,” said Dawn O’Connell, assistant secretary for preparedness and response at the HSS.
Trust Between Patient, Provider Key to Reducing Vaccine Hesitancy
June 20th 2024Research presented at ASHP 2024 found that concerns around the safety of COVID-19 vaccines and the credibility of information from public health authorities were the biggest drivers of vaccine hesitancy during the COVID-19 pandemic.
FDA Issues CRL for Heplisav-B in Adults With ESRD on Hemodialyis
May 14th 2024Dynavax plans to meet with the FDA to discuss how the company can provide additional data to support the approval of its 4-dose Heplisav-B regimen and expand protection for adults with end-stage renal disease (ESRD) on hemodialysis.